Ethical MedTech EU Compliance
EthicalMedTech is a platform, supported by MedTech Europe, dedicated to ethics and compliance projects in the European MedTech industry.
WORLDSymposium™ 2020 has been found to be Compliant in accordance with the principles and standards set out in the MedTech Europe Code of Ethical Business Practice. This decision is posted on www.ethicalmedtech.eu.
WORLDSymposium™ 2020 Genetic Counselor CEUs
The program for WORLDSymposium 2020 will be submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification.
To claim genetic counselor credits from NSGC, you will need to attend each session and complete the daily session evaluations, which will be sent via email at the end of each day of the conference. There will be 3 total evaluations, one for WORLDSymposium, one for Emerging Trends (if attended), and one for Genetic Counselors (NSGC, if applicable). In addition, for NSGC credit, you will need to pay a $25 NSGC fee at the time of registration. If you have any questions, email Amber Brown at firstname.lastname@example.org. Deadline to claim credit will be March 19, 2020.
2020 ACCME Accreditation
WORLDSymposium 2020 is jointly provided by Postgraduate Institute for Medicine and WORLDSymposia.
This activity has been designed for geneticists, pediatricians, primary care practitioners, registered nurses, nurse practitioners, physician assistants, genetic counselors, and other researchers and health care practitioners involved with the identification of disease mechanisms and potential treatments, or involved with the diagnosis and management of individuals with lysosomal diseases. In addition, the content is designed to be applicable to individuals with lysosomal diseases and their family members, as well as advocacy groups involved with raising awareness.
At the completion of this program, the participant should be able to:
- Identify the key diagnostic features of lysosomal diseases.
- Utilize recent diagnostic tests for lysosomal diseases.
- Compare the relative advantages and disadvantages of each therapy currently available.
- Identify unmet needs of each disease being discussed.
- Formulate new research ideas for these lysosomal diseases.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and WORLDSymposia. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
This activity has been approved for AMA PRA Category 1 Credit(s)™. This activity is approved for ANCC credit for nurses. Full accreditation information coming soon.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Gudrun Echterhoff prior to the live event at email@example.com